Healthcare - Biotechnology - NASDAQ - US
$ 6.69
-11.6 %
$ 427 M
Market Cap
-5.82
P/E
Price Target
Average
203.94%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
26.82%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Larimar Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for LRMR of $20.3 , with forecasts ranging from a low of $14 to a high of $25 .
LRMR Lowest Price Target
Wall Street Target
14 USD
109.27%
LRMR Average Price Target
Wall Street Target
20.3 USD
203.94%
LRMR Highest Price Target
Wall Street Target
25 USD
273.69%
REVENUE FORECAST
Revenue Forecast Chart LRMR
EBIT FORECAST
EBIT Forecast Chart LRMR
NET INCOME FORECAST
Net Income Chart LRMR